4
Changes in Ownership
Solid Biosciences Inc. Filed Acc 0001193125-26-034085
Chief Regulatory Officer sold 26,535 shares at $6.44 ($170,803)
- Chief Regulatory Officer acquired 82,550 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hanrahan Jessie Chief Regulatory Officer | 2026-01-29 | Option exercise 10b5-1 | +54,925 | 81,585 | D | ||
| Hanrahan Jessie Chief Regulatory Officer | 2026-01-31 | Option exercise 10b5-1 | +27,625 | 109,210 | D | ||
| Hanrahan Jessie Chief Regulatory Officer | 2026-02-02 | Sale 10b5-1 | −26,535 | $6.44 | $170,803 | 82,675 | D |
| Derivatives | |||||||
| Hanrahan Jessie Chief Regulatory Officer | 2026-01-29 | Option exercise · Performance Stock Units 10b5-1 | −54,925 | 0 | D | ||
| Hanrahan Jessie Chief Regulatory Officer | 2026-01-29 | Grant or award · Employee Stock Option (Right to Buy) 10b5-1 | +190,000 | 190,000 | D | ||
| Hanrahan Jessie Chief Regulatory Officer | 2026-01-29 | Grant or award · Restricted Stock Units 10b5-1 | +95,000 | 95,000 | D | ||
| Hanrahan Jessie Chief Regulatory Officer | 2026-01-31 | Option exercise · Restricted Stock Units 10b5-1 | −27,625 | 82,875 | D | ||
| Open-market sales · 26,535 sh · avg $6.44 · $170,803 | |||||||
Loading xslF345X05/ownership.xml…